NIHR HTA Programme bulletin - September 2016

Latest news

Largest UK trial of treatment for prostate cancer publishes first results

Active monitoring is as effective as surgery and radiotherapy, in terms of survival at 10 years, reports the largest study of its kind, funded by the NIHR. Results published in New England Journal of Medicine, show that all three treatments result in similar, and very low, rates of death from prostate cancer. Surgery and radiotherapy reduce the risk of cancer progression over time compared with active monitoring, but cause more unpleasant side-effects. Read the full article.

Revised DH contract will benefit researchers and patients

The Department of Health (DH) and the Health Research Authority (HRA) have been working together to review the standard DH contract for NIHR funded research. Research projects funded by an NIHR research programme will be able to receive payments for start-up in advance of ethical approval. This enables more rapid, efficient and streamlined set-up of research and quicker translation of research into patient benefit. Read the full article

Latest funding opportunities

Commissioned funding stream

We currently have 15 funding opportunities available in a number of health areas. For more details and to apply please visit the HTA Commissioned webpage.

Researcher-led  funding stream

We welcome proposals on topics or research questions within the programmes remit. For more details and to apply please visit the HTA researcher-led webpage

Useful Information

Celebrating the work of our reviewers

Next week is Peer Review Week, 19 - 25 September 2016, we wanted to take this opportunity to thank our reviewers.

You are vital to maintaining and improving the quality of NIHR research, by identifying key research topics, helping select the best projects and helping shape our open access reports, for which we are incredibly grateful.

Share what peer reviewing means to you by tweeting @OfficialNIHR

Sign up now to become a reviewer.